Newsbenzinga
Here's How Much $100 Invested In Halozyme Therapeutics 5 Years Ago Would Be Worth Today
· Published
Article summary
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 5 years by 12.8% on an annualized basis producing an average annual return of 24.48%. Currently, Halozyme Therapeutics has a market
An excerpt from the original article.
Comments —
Loading comments…